The dose of adjuvant chemotherapy for breast cancer may be an important factor in the success of the treatment program. In a retrospective analysis, the authors determined whether patients who were irradiated either postoperatively (N = 29) or as part of primary treatment (N = 13) received a lower d
✦ LIBER ✦
Feasibility of dose–intensive continuous 5–fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancer
✍ Scribed by Georgiana Ellis; Robert B. Livingston
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 405 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The effect of postoperative and primary
✍
Jedd F. Levine; C. Norman Coleman; Richard S. Cox; Gordon R. Ray; William M. Rog
📂
Article
📅
1984
🏛
John Wiley and Sons
🌐
English
⚖ 457 KB
👁 2 views
A prospective, randomized evaluation of
✍
James E. Krook; Michael J. O';Connell; Harry S. Wieand; Robert W. Beart Jr; John
📂
Article
📅
1991
🏛
John Wiley and Sons
🌐
English
⚖ 447 KB
👁 1 views
This study evaluated combined 5-fluorouracil(5FU) and doxorubicin as postoperative adjuvant chemotherapy for patients who had undergone potentially curative resection of a primary gastric adenocarcinoma. One hundred twenty-five eligible and evaluable patients were stratified according to extent of s